This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (713) Cancer and Clinical Trials (47) Clinical Cancer Research (128) Innovations and Technology in Cancer Care (563) Innovations in Cancer Diagnostic and Decision Support (119)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/84607, first published .
Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial

Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial

Stereotactic Adaptive Radiation Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer to Minimize Gastrointestinal Toxicity (ARTIA-Pancreas): Protocol for a Single-Arm Prospective Trial

Authors of this article:

Lauren E Henke1 Author Orcid Image ;   Hyun Kim2 Author Orcid Image ;   Eric Laugeman2 Author Orcid Image ;   Steven Kohlmyer3 Author Orcid Image ;   Claire McCann3 Author Orcid Image ;   Kate Pietrovito3 Author Orcid Image ;   Kenneth Russell3 Author Orcid Image ;   Jennifer Woo3 Author Orcid Image ;   Alex T Price1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Lauren E Henke   1 , MS, MD ;   Hyun Kim   2 , MD ;   Eric Laugeman   2 , MS ;   Steven Kohlmyer   3 , MS ;   Claire McCann   3 , PhD ;   Kate Pietrovito   3 , MS ;   Kenneth Russell   3 , MD ;   Jennifer Woo   3 , BSc ;   Alex T Price   1 , PhD, DABR

1 Department of Radiation Oncology, Seidman Cancer Center, University Hospitals, Cleveland, OH, United States

2 Department of Radiation Oncology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States

3 Varian Medical Systems, LLC, A Siemens Healthineers Company, Palo Alto, CA, United States

Corresponding Author:

  • Alex T Price, PhD, DABR
  • Department of Radiation Oncology
  • Seidman Cancer Center, University Hospitals
  • 10900 Euclid Avenue
  • Cleveland, OH 44106
  • United States
  • Phone: 1 216-844-3951
  • Email: alex.price@uhhospitals.org